-----------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------------------------------------------------------------
FORM 8-K
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) May 29, 1997
CONMED CORPORATION
------------------------------------------------------
(Exact name of registrant as specified in its charter)
New York 0-16093 16-0977505
- ------------------------------- ------------ -------------------
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)
310 Broad Street, Utica, New York 13501
--------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
(315) 797-8375
----------------------------------------------------
(Registrant's telephone number, including area code)
<PAGE>
Item 5. Other Events
On May 29, 1997, CONMED Corporation (the Company) signed an
asset purchase agreement whereby the Company will acquire a product line from
Davol Inc., a subsidiary of C.R. Bard, Inc. The acquisition, which includes
approximately $25 million of net sales, is scheduled to close on June 30, 1997.
Item 7. Financial Statements and Exhibits
(c) Exhibits
1. Press release dated May 29, 1997.
<PAGE>
Signature
Pursuant to the requirements of Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CONMED CORPORATION
By:/s/ Robert D. Shallish, Jr.
---------------------------
Robert D. Shallish, Jr.
Vice President-Finance
Dated: June 18, 1997
<PAGE>
[GRAPHIC-COMPANY LETTERHEAD] NEWS RELEASE
May 29, 1997
CONTACT: ROBERT D. SHALLISH, JR.
(315) 797-8375
EXT. 2219
FOR RELEASE: 7:00 AM (EDT) May 29, 1997
CONMED To Acquire Surgical Suction Connecting Tubing
and Suction Instruments From a Subsidiary of C.R. Bard, Inc.
Utica, New York - CONMED CORPORATION (NASDAQ: CNMD) today announced the
signing of an agreement with Davol Inc., a subsidiary of C.R. Bard, Inc. (NYSE:
BCR) for the acquisition of Davol Inc.'s Yankauer, Poole, Frazier and
Sigmoidoscopic and connecting tubing surgical suction instrument product line.
The products are used routinely by physicians in surgical procedures and have
sales of approximately $25 million. Terms of the purchase were not disclosed.
The Agreement does not include Davol Inc.'s performance irrigation product line.
Subject to clearance under the Hart Scott Rodino Anti-trust
Improvements Act of 1976, the acquisition is scheduled to close on June 30,
1997.
Eugene R. Corasanti, President, Chief Executive Officer and Chairman of
the Board, said, "The purchase of this product line is a fine addition to our
CONMED family of products. It will fit well with our recently reorganized sales
structure and our medical manufacturing expertise."
The products are currently manufactured in facilities of Davol Inc. in
Cranston, Rhode Island and Lawrence, Kansas. The production in the Cranston
plant will be moved to CONMED's Utica location while the Lawrence production
will be continued in the Lawrence facility.
CONMED Corporation is a manufacturer of electrosurgery, heart
monitoring and other medical products used primarily in hospital operating rooms
and other critical care areas. The Company distributes its products worldwide
from manufacturing and warehousing facilities in Utica and Rome, New York;
Denver Colorado; Dayton, Ohio and El Paso, Texas.
